Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumour”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003616
What this trial is testing

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00612716
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Masonic Cancer Center, University of Minnesota 6
Not applicableLooking for participantsNCT05873608
What this trial is testing

Communication Issues in Patient and Provider Discussions of Immunotherapy

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Emory University 125
Not applicableStudy completedNCT01641068
What this trial is testing

Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms

Who this might be right for
Breast CarcinomaCancer SurvivorCognitive Side Effects of Cancer Therapy+1 more
University of Washington 20
Not applicableLooking for participantsNCT05837260
What this trial is testing

Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Royal Marsden NHS Foundation Trust 120
Testing effectiveness (Phase 2)Study completedNCT00381797
What this trial is testing

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Who this might be right for
Childhood Cerebral Anaplastic AstrocytomaChildhood OligodendrogliomaChildhood Spinal Cord Neoplasm+3 more
National Cancer Institute (NCI) 97
Not applicableEnded earlyNCT03328858
What this trial is testing

Ketogenic Diet in Children With Malignant or Recurrent/Refractory Brain Tumor

Who this might be right for
Brain Tumors
Nicklaus Children's Hospital f/k/a Miami Children's Hospital 2
Not applicableEnded earlyNCT03943082
What this trial is testing

Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials

Who this might be right for
Malignant NeoplasmHematopoietic and Lymphoid Cell Neoplasm
University of California, San Francisco 252
Not applicableLooking for participantsNCT00242723
What this trial is testing

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

Who this might be right for
Thoracic CancersMalignant Pleural Mesotheliomas NOSLung Cancer NOS+3 more
National Cancer Institute (NCI) 1,559
Early research (Phase 1)Study completedNCT00037817
What this trial is testing

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Who this might be right for
Advanced Esophageal CancersPrimary Small Cell Lung CancersNon-Small-Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 34
Not applicableUnknownNCT04353050
What this trial is testing

Atypical MOLes and Melanoma Early Detection Study (MoleMed)

Who this might be right for
MelanomaMelanoma (Skin)Moles+9 more
Russian Academy of Medical Sciences 350
Testing effectiveness (Phase 2)Ended earlyNCT03391050
What this trial is testing

APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma

Who this might be right for
Melanoma
Aprea Therapeutics 3
Not applicableStudy completedNCT01270360
What this trial is testing

Validation of an Alternative Biological Test to Increase the Detection Sensitivity of a Colon Tumour

Who this might be right for
Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 502
Early research (Phase 1)Looking for participantsNCT05877924
What this trial is testing

NBL-020 Injection in Subjects With Advanced Malignant Tumors.

Who this might be right for
Advanced Malignant Tumors
NovaRock Biotherapeutics, Ltd 200
Large-scale testing (Phase 3)Study completedNCT00002596
What this trial is testing

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorTesticular Germ Cell Tumor
Memorial Sloan Kettering Cancer Center 270
Not applicableEnrolling By InvitationNCT07376980
What this trial is testing

The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer

Who this might be right for
Rectal NeoplasmsRectal Neoplasms MalignantRectal Cancer+1 more
Korea University Anam Hospital 450
Not applicableUnknownNCT06074718
What this trial is testing

Clinical Value of Prick Therapy Combined With Wheat Grain Moxibustion in the Treatment of Spleen Deficiency and Dampness Obstructed Cancer

Who this might be right for
Pricking Therapy on the Back Shu PointsWheat Grain Moxibustion on the Back Shu Points
Jiangsu Taizhou People's Hospital 100
Not applicableLooking for participantsNCT02474160
What this trial is testing

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+1 more
National Cancer Institute LAO 5,000
Testing effectiveness (Phase 2)Study completedNCT01024946
What this trial is testing

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 11
Early research (Phase 1)Study completedNCT02303678
What this trial is testing

D2C7 for Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaBrain Tumor, Recurrent
Darell Bigner 81
Next Page